https://lamtherapeutics.com/2013/06/lam-therapeutics-launches-operations-to-develop-drugs-for-rare-lung-disease-lymphangioleiomyomatosis-lam/2017-12-20T10:56:35-05:00https://lamtherapeutics.com/2016/02/lam-therapeutics-closes-40m-in-financing-and-announces-two-clinical-stage-programs-in-rare-diseases-and-cancer/2017-12-20T10:57:06-05:00https://lamtherapeutics.com/2017/03/lam-therapeutics-announces-close-of-58m-series-c-financing-and-new-clinical-program-in-cancer/2017-12-20T10:57:29-05:00https://lamtherapeutics.com/2017/10/lymphangioleiomyomatosis-overview-new/2017-11-29T23:05:56-05:00https://lamtherapeutics.com/2017/11/lam-therapeutics-announces-progress-of-its-clinical-portfolio-with-fda-clearance-of-new-trial-in-leukemia-and-advancement-of-clinical-trial-in-lymphoma/2017-12-20T10:54:35-05:00